Hepatic Resection Clinical Trial
— CRUNSHOfficial title:
Clamp-Crushing vs. Stapler Hepatectomy for Transection of the Parenchyma in Elective Hepatic Resection: CRUNSH - A Randomized Controlled Trial
There is clinical uncertainty and ongoing discussion among liver surgeons regarding the optimal method of parenchymal transection in patients undergoing elective hepatic resection. While the clamp-crushing technique still represents the reference technique for routine liver resections, transection of liver parenchyma using vascular staplers may offer a new and safe technique potentially reducing intraoperative blood loss, operation time as well as peri-operative morbidity. As morbidity of patients undergoing hepatic resection remains high, approaches to lower peri-operative complications are urgently required. Due to the lack of evidence it has to be evaluated, if the technique of stapler hepatectomy decreases intraoperative blood loss as a highly relevant predictor of peri-operative complications, patients' hospital stay and finally health care expenditures. These advantages would favor stapler hepatectomy to be applied in routine liver resections. As RCTs are generally considered to generate the most valid scientific evidence on a treatment's effects, the present trial evaluates potential benefits of stapler hepatectomy in a randomized fashion.
Status | Completed |
Enrollment | 130 |
Est. completion date | March 2012 |
Est. primary completion date | October 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients scheduled for elective hepatic resection - Stapler hepatectomy and clamp-crushing feasible based on preoperative imaging - Age equal or greater than 18 years - Informed consent Exclusion Criteria: - Participation in concurrent intervention trials - Expected lack of compliance - Impaired mental state or language problems |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | Department of General, Visceral and Transplantation Surgery, University of Heidelberg | Heidelberg | BW |
Lead Sponsor | Collaborator |
---|---|
Nuh Rahbari |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intraoperative blood loss | 2.5 hours | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01890408 -
Continuous Preperitoneal Infusion of Ropivacaine After Open Liver Resection: Effect on Post-operative Recovery and Morbidity.
|
Phase 2 | |
Recruiting |
NCT04849455 -
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
|
Phase 4 | |
Completed |
NCT00273247 -
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
|
Phase 3 | |
Completed |
NCT02056028 -
Bile Leak After Liver Surgery
|
N/A | |
Completed |
NCT04024956 -
Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage in Hepatobiliary and Pancreatic Surgery
|
N/A |